Walgreens Mulls Bond Sale As JPMorgan Gauges Investor Appetite: Report - Walgreens Boots Alliance (NASDAQ:WBA)

Original Article:

Source: Link

JP Morgan Chase & Co. JPM is reportedly gauging investor interest in a possible issuance of high-yield bonds by Walgreens Boots Alliance, Inc. WBA, aimed at managing the drug-store chain’s recently downgraded near-term debt obligations. Preliminary discussions on pricing suggest a yield in the vicinity of 7.5%, reported Bloomberg, citing people familiar with the discussions. The specific size and duration of the deal have not been finalized. Walgreens currently holds a $1.16 billion note maturing on November 18, trading close to par, and a £300 million ($387 million) bond due in late 2025, as per Bloomberg data. Should Walgreens proceed with a bond sale, it would mark their first issuance since being downgraded to junk status by both Moody’s Ratings and S&P Global Ratings. Also Read: Rite Aid Forges Path To Financial Recovery With Major Settlement: Report This move would entail significantly higher costs, with the highest coupon rate currently at 4.8% on a 2044 bond issued a decade ago. In January, Walgreens nearly halved its dividend following a CEO change. Meanwhile, Rite Aid Corp RADCQ is in bankruptcy, CVS Health Corporation CVS faces retail challenges, and Walmart Inc. WMT scrapped plans for low-cost clinics due to cost and reimbursement issues. S&P’s recent BB downgrade indicates Walgreens’ leverage ratio could remain above five times into fiscal 2025 and beyond, Bloomberg added. Price Action: WBA shares are trading higher by 2.24% to $11.41 at last check Thursday. Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. Photo: refrina/Shutterstock.com Read Next: